Thursday, August 26, 2004
--------------------------------------------------------------------------------
Cardiology
Total Artificial Heart Implant Increases Survival to Transplantation
The implant resolved hemodynamic abnormalities and promoted end-organ recovery and mobility in a study published in the Aug. 26 issue of the New England Journal of Medicine.
Medscape Medical News 2004
Weekly Maintenance Fluconazole Reduces Rate of Recurrent Vulvovaginal Candidiasis
Although this suppressive therapy successfully and safely controlled this poorly managed condition, a long-term cure remains elusive, researchers report in the Aug. 26 issue of the New England Journal of Medicine.
Medscape Medical News 2004
Glucocorticoids May Not Reduce Bone Mineral Density in Children With Nephrotic Syndrome
The editorialist finds the results from this cross-sectional study reassuring but notes numerous limitations. The research was published in the Aug. 26 issue of the New England Journal of Medicine.
Medscape Medical News 2004
Diabetes & Endocrinology
Metabolic Syndrome Significantly Increases Risk of Death
People with the metabolic syndrome are much more likely to die from coronary heart disease, cardiovascular disease, or any cause than those without the syndrome, according to a study published on Aug. 24 in the rapid access issue of Circulation.
Reuters Health Information 2004
Psychiatry & Mental Health
Telephone Psychotherapy May Provide Relief From Depression Symptoms
Intervention shows stronger results than a care management program for patients with moderate depression, according to a study in the Aug. 25 issue of JAMA.
Medscape Medical News 2004
Medscape Alert
Infliximab Associated With Risk of Hematologic, Neurologic Adverse Events
In postmarketing reports, infliximab was associated with risk of leukopenia, neutropenia, pancytopenia, and systemic vasculitis, according to the FDA.
Medscape Medical News 2004
Rheumatology
FDA Study Finds Vioxx Increases MI Risk
Patients taking Merck & Co. Inc.'s Vioxx (rofecoxib) arthritis drug had a 50% greater chance of myocardial infarction and sudden cardiac death than individuals using Pfizer Inc.'s rival Celebrex (celecoxib) medicine, according to a large study financed by the U.S. Food and Drug Administration.
Reuters Health Information 2004
Featured CME News
Antidepressant Treatment Improves Poststroke Survival
In a placebo-controlled trial published in the October 2003 issue of the American Journal of Psychiatry, treatment with either fluoxetine or nortriptyline for 12 weeks during the first 6 months after stroke improved survival for both depressed and nondepressed patients.
Medscape Medical News 2003
Hematology-Oncology
Iressa Tied to More Cases of Interstitial Pneumonia in Japan AstraZeneca Plc. said on Wednesday a new study in Japan showed a higher rate of a potentially fatal side effect in lung cancer patients treated with Iressa (gefitinib) than that demonstrated in an earlier analysis.
Reuters Health Information 2004
General Surgery
Endovascular Aneurysm Repair Compares Favorably With Open Repair
In a randomized trial published online in The Lancet on Aug. 25, the 30-day operative mortality rate in patients with large abdominal aortic aneurysms was two thirds less with endovascular than with open repair.
Medscape Medical News 2004
To remove your address from all Medscape mailing lists, please write to us at medscapeunsub@webmd.net.
ADVERTISEMENT - Learn more about MPDs and long-term management.
An ideal clinical intervention for thrombocythemia would offer platelet-specific control and a favorable long-term safety profile.
--------------------------------------------------------------------------------
Medscape News
Access all of Medscape's medical news stories online.
--------------------------------------------------------------------------------
We welcome your comments, write to us at news@webmd.net
Mailing Address
WebMD Medscape
Attn: email newsletters
224 W. 30th Street
New York, NY 10001
--------------------------------------------------------------------------------
Unsubscribe from this newsletter.
Subscribe to this newsletter.
Not a Medscape Member?
Forgot your login info?
Cannot read this newsletter? Prefer the TEXT version?
www.medscape.com/dnetext
Difficulty linking to a news story?
Need additional support?
--------------------------------------------------------------------------------
